European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism.

BACKGROUND: Direct oral anticoagulants for the treatment of venous thromboembolism are supported by robust clinical trial evidence. Despite published guidance, general practitioners are faced with increasingly complex decisions and implementation remains sub-optimal in certain real-world scenarios. METHODS: A two stage formal consensus exercise was performed to formulate consensus statements and a summary guide, facilitating optimal management of direct oral anticoagulants in venous thromboembolism patients by generalist physicians across Europe. An online questionnaire distributed to a broad panel (Phase 1), followed by a virtual panel discussion by an expert group (Phase 2) were conducted. Phase 1 statements covered nine management domains, and were developed via a literature review and expert steering committee. Participants rated statements by their level of agreement. Phase 1 responses were collated and analysed prior to discussion and iterative refinement in Phase 2. RESULTS: In total 56 participants from across Europe responded to Phase 1. The majority had experience working as general practitioners. Consensus indicated that direct oral anticoagulants are the treatment of choice for managing patients with venous thromboembolism, at initiation and for extended treatment, with a review at three to six months to re-assess treatment effect and risk profile. Direct oral anticoagulant choice should be based on individual patient factors and include shared treatment choice between clinicians and patients; the only sub-group of patients requiring specific guidance are those with cancer. CONCLUSION: Results demonstrate an appreciation of best practices, but highlight challenges in clinical practice. The patient pathway and consensus recommendations provided, aim to highlight key considerations for general practice decision making, and aid optimal venous thromboembolism treatment.

What factors influence symptom reporting during an emerging infectious disease outbreak? A rapid review of the evidence

IntroductionDuring any emerging infectious disease outbreak, people with symptoms of the illness are often asked to report their symptoms to the health service in a timely manner, to facilitate contact tracing. Numerous factors may influence an individuals willingness to report these symptoms. Understanding these factors has become urgent during the COVID-19 pandemic. ObjectiveTo determine which factors influence symptom reporting during an emerging infectious disease outbreak. MethodsWe conducted a rapid review of the evidence. We included papers based on primary research; published in a peer-reviewed journal; written in English; included factors associated with symptom reporting or accessing healthcare; and related to a major public health incident involving an infectious disease outbreak. Main resultsFive themes were identified as facilitators of symptom reporting or accessing healthcare: accurate and informative communication; symptom severity; concern about exposure; ease of access; and relationship with the healthcare provider. Seven themes were identified as barriers of symptom reporting or accessing healthcare: lack of knowledge; fear; stigmatization; invasion of privacy; low concern about symptoms; economics; and practicalities of attending a healthcare facility. Discussion & ConclusionIf contract tracing services are to be effective, members of the public need to have the capability, opportunity and motivation to use them. The themes identified should be used to evaluate the information provided to the public about such a service, the routes of access, and the underlying policies relating to the service, in order to ensure that as many people as possible with relevant symptoms will make contact.